deal (Page 2)

phototechno Abeona Therapeutics (NASDAQ:ABEO) traded higher on Thursday after the company announced a partnership with eye care drug developer Beacon to evaluate its patented technology, AAV204, for gene therapies. Per the terms, Beacon, which belongs to Syncona’s clinical portfolio of companies, will have a non-exclusive right to evaluate AAV204 capsidContinue Reading

JHVEPhoto/iStock Editorial via Getty Images Accenture’s (NYSE:ACN) deal to acquire India-based semiconductor design services provider Excelmax could be accretive revenue and improve its technological prowess, investment firm Baird said. The deal, which could add roughly 0.1% to annualized revenue, is also likely to add to “key areas” for Accenture, includingContinue Reading